Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- 5.00 Approved Continuing Education (ACE)
- 5.00 Association of Social Work Boards (ASWB)
$0.00
End-of-life decisions can be complex and challenging. Health and mental health professionals can help with their expertise, whether it is for the person facing death, their family, surrogate decision makers, or caregiver. It is vital for health and mental health professionals to learn when and how to include end-of-life discussions into their sessions, assist with decision making and planning, and learn the differences between palliative and end-of-life care.
- 6.00 Approved Continuing Education (ACE)
- 6.00 Association of Social Work Boards (ASWB)
$36.00
Without proper self-care, boundaries, and awareness (transference), therapists become vulnerable to burnout and vicarious traumatization. This can result in a risk of therapeutic effectiveness, loss of trust with clients, and possible ethical crossings or violations. This course supports professionals practicing competence, while utilizing self-care and boundaries to minimize burnout while practicing compassion for the clients that they serve.
- 6.00 Approved Continuing Education (ACE)
- 6.00 Association of Social Work Boards (ASWB)
$36.00
Ethical issues do not exist within a vacuum; rather, they emerge, evolve, and adapt within the sociocultural context of a particular society. In past decades, the field of professional ethics has received increased attention. Much of the discussion began in the 1960s in the medical field, where the blending of ethics, legalities, and medicine has become known as bioethics.
- 0.36 AANP Contact Hours
- 0.36 AANP Pharmacology Contact Hours
- 0.50 AMA PRA Category 1 Credit™
$0.00
Agitation is among the most common behavioral symptoms in patients with dementia, including Alzheimer’s dementia. It exacts a significant burden on patients because it is associated with not only greater morbidity and mortality, but also a faster cognitive and functional decline. This activity reviews pharmacological treatment options, both a newly approved agent that is the first ever to be indicated specifically for the treatment of agitation associated with dementia due to Alzheimer’s disease and also an array of agents in development.
- 2.00 AMA PRA Category 1 Credit™
$15.00
Frontotemporal dementia (FTD) is a group of degenerative brain disorders causing progressive deterioration in behavior, language, and/or movement. There are presently approximately 60,000 people with FTD in the United States. Onset generally occurs between 50 and 70 years of age, making FTD one of the most common presenile dementias. FTD affects the frontal and temporal lobes of the brain, which control emotions, judgment, personality, memory and language. The clinical diagnosis of FTD can be challenging, as some symptoms overlap with Alzheimer disease and other forms of dementia.
- 5.00 MOC
- 5.00 Approved Continuing Education (ACE)
- 5.00 AMA PRA Category 1 Credit™
- 5.00 ANCC
- 5.00 Association of Social Work Boards (ASWB)
$30.00
Since the discovery of HIV, scientists have made major inroads in understanding modes of transmission, infectivity, and pathogenicity. Knowledge about the characteristics and behavior of this human retrovirus and its complex mechanisms of immunopathogenesis has helped to develop targeted therapeutic interventions and vaccine strategies. Sophisticated techniques have been and are being developed to diagnose infection, to monitor immune decline, to monitor response to therapy and disease progression, and to accurately detect and diagnose opportunistic diseases.
- 1.00 AMA PRA Category 1 Credit™
$15.00
Healthcare professionals should know best clinical practices in opioid prescribing, including the associated risks of opioids, approaches to the assessment of pain and function, and pain management modalities. Patients with moderate-to-severe chronic pain who have been assessed and treated, over a period of time, with non-opioid pharmacologic or nonpharmacologic pain therapy without adequate pain relief are considered to be candidates for a trial of opioid therapy.
- 5.00 AMA PRA Category 1 Credit™
- 5.00 Association of Social Work Boards (ASWB)
$30.00
Victims of domestic and sexual violence suffer emotional, psychological, and physical abuse, all of which can result in both acute and chronic signs and symptoms of physical and mental disease, illness, and injury. Frequently, the injuries sustained require abused victims to seek care from healthcare professionals immediately after their victimization. Subsequently, physicians and nurses are often the first healthcare providers that victims encounter and are in a critical position to identify victims in a variety of clinical practice settings where victims receive care.
- 3.00 AMA PRA Category 1 Credit™
$18.00
Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, abuse, and diversion of prescription drugs in America, particularly prescription opioids, has increased dramatically in recent years and has been identified as a national public health epidemic. A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids.
- 5.00 AMA PRA Category 1 Credit™
$30.00
Changes in the delivery of health care and advances in technology have moved many surgical procedures out of the traditional operating room. As such, physicians in a wide variety of settings are increasingly using moderate sedation/analgesia (often referred to as conscious sedation). Knowledge and skill in managing potential complications of moderate sedation is essential. This course will review the available guidelines for the provision of moderate sedation and considerations for different patient populations, settings, and procedures.